- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Disease State Education: Treatment & Current Treatment Guidelines – Agitation Associated With Alzheimer’s Dementia

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Disease State Education: Treatment & Current Treatment Guidelines – Agitation Associated With Alzheimer’s Dementia
This is a Virtual Event for PsychU members in DC, Maryland, North Carolina, South Carolina, and Virginia.
In this presentation, topics of discussion are:
- Discuss treatment plans are recommended for patients with Alzheimer’s disease
- Discuss comprehensive management plan
- Discuss unmet needs for treatment of agitation in Alzheimer’s dementia

Chris Brodie, PhD (OPDC)
Medical Science Liaison

Justin Wimmer, PharmD
Medical Science Liaison
Speakers Chris Brodie, PhD and Justin Wimmer, PharmD employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)